Rakovina Therapeutics

Vancouver, Canada

Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.

$1.5M raised

Jan 2026

Post-IPO Debt

Biotechnology Life Science Oncology

Top Investors

Red Thread Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rakovina Therapeutics

How much funding has Rakovina Therapeutics raised?

Rakovina Therapeutics has raised $1.5M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in January 2026.

Who are Rakovina Therapeutics's investors?

Rakovina Therapeutics's investors include Red Thread Ventures.

Where is Rakovina Therapeutics headquartered?

Rakovina Therapeutics is headquartered in Vancouver, Canada.

What does Rakovina Therapeutics do?

Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.

What stage is Rakovina Therapeutics at?

Rakovina Therapeutics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 27, 2026.

MLA

"Rakovina Therapeutics — Funding & Investors." VCBacked, January 27, 2026, https://www.vcbacked.co/company/rakovina-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Rakovina Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rakovina-therapeutics

Wikipedia (cite web)

{{cite web |title=Rakovina Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rakovina-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 27, 2026.